skip to main content

S. 2074: Mainstreaming Addiction Treatment Act of 2019

Call or Write Congress

React to this bill with an emoji

Save your opinion on this bill on a six-point scale from strongly oppose to strongly support

Add Note All Positions »
(About Ads | Hide These Ads)

About the bill

Should we loosen restrictions on one of the supposedly-best ways to treat opioid addiction, or would it actually just make the problem worse?

Context

The opioid crisis caused more than 68,500 deaths last year. That exceeds the peak year of deaths for AIDS, car crashes, or gun violence. The good news, if any, is that opioid deaths dropped by about -5% in 2018 from the peak in 2017.

One of the most effective ways to treat opioid addiction is through a medication called buprenorphine. However, the Drug Addiction Treatment Act of 2000, passed as part of the Children’s Health Act of 2000 — well before the 2010s opioid crisis — often stands in the way.

The law requires physicians and doctors to obtain a waiver from the Drug Enforcement Administration ...

Sponsor and status

Photo of sponsor Margaret “Maggie” Hassan

Margaret “Maggie” Hassan

Sponsor. Junior Senator for New Hampshire. Democrat.

Thumbnail of bill text
Read Text »
Last Updated: Jul 10, 2019
Length: 8 pages
Introduced
Jul 10, 2019
116th Congress (2019–2021)
Status

Introduced on Jul 10, 2019

This bill is in the first stage of the legislative process. It was introduced into Congress on July 10, 2019. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Prognosis
2% chance of being enacted according to Skopos Labs (details)
Source
Congress.gov

Position statements

What stakeholders are saying

Reynolds Consultants As a Psychiatric Pharmacist that has practiced for 38 years I have a great deal of knowledge about the clinicians who treat Opiate Use Disorders. This is not a topic taught in medical school, nor is it a skill that is ...

History

Jul 10, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

If this bill has further action, the following steps may occur next:
—
 
Passed Committee

—
 
Passed Senate

—
 
Passed House

—
 
Signed by the President

S. 2074 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 2074. This is the one from the 116th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2074 — 116th Congress: Mainstreaming Addiction Treatment Act of 2019.” www.GovTrack.us. 2019. October 25, 2020 <https://www.govtrack.us/congress/bills/116/s2074>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.